What is the appropriate ICD‑10‑CM code for an unspecified low‑density abnormality of the pancreas on imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10-CM Code for Low-Density Pancreatic Abnormality

For an unspecified low-density abnormality of the pancreas on imaging, use ICD-10-CM code K86.9 (Disease of pancreas, unspecified).

Coding Rationale

When imaging reveals a low-density pancreatic abnormality without further characterization, the appropriate code depends on what additional clinical information is available:

Primary Code Options:

  • K86.9 - Disease of pancreas, unspecified

    • Use this when the abnormality is truly unspecified and no additional clinical context exists
    • This is the most appropriate "holding" code pending further workup
  • K86.89 - Other specified diseases of pancreas

    • Consider this if there are some descriptive features but no definitive diagnosis

If Specific Entities Are Suspected:

The low-density appearance on imaging can represent several distinct pathologies, each with its own code:

Fatty replacement/lipomatosis:

  • No specific ICD-10 code exists for pancreatic lipomatosis
  • Use K86.89 (Other specified diseases of pancreas) 1

Cystic lesions:

  • K86.2 - Cyst of pancreas (for simple cysts)
  • D13.6 - Benign neoplasm of pancreas (for characterized benign cystic neoplasms)

Inflammatory conditions:

  • K85.x - Acute pancreatitis (with appropriate 4th digit)
  • K86.1 - Other chronic pancreatitis
  • K86.0 - Alcohol-induced chronic pancreatitis

If malignancy suspected:

  • C25.x - Malignant neoplasm of pancreas (with appropriate site-specific 4th digit)
  • Do NOT code as malignant without tissue diagnosis 2

Clinical Context Matters

The imaging appearance of "low density" requires correlation with:

  • Patient demographics - Age, diabetes status, BMI
  • Clinical presentation - Symptomatic vs incidental finding
  • Imaging characteristics - Size, location, enhancement pattern, associated findings
  • Risk factors - Family history, genetic syndromes, chronic pancreatitis

Imaging Workup Considerations:

According to current guidelines, further characterization should include 3:

  • MRI/MRCP - Superior for characterizing small lesions and cystic components
  • Multiphase CT - 90% sensitive for solid pancreatic neoplasms >2 cm 3
  • EUS - Highest sensitivity (>90%) for small lesions and allows tissue sampling 4

Common Pitfalls to Avoid:

  1. Do not code as malignant (C25.x) without histologic confirmation - Even highly suspicious imaging findings require tissue diagnosis before using cancer codes 2

  2. Avoid using R93.5 (Abnormal findings on diagnostic imaging of other abdominal regions) - This is too nonspecific when pancreatic pathology is identified

  3. Document the need for follow-up - Low-density abnormalities often require serial imaging or tissue sampling to establish definitive diagnosis 5

  4. Consider secondary codes - If associated with diabetes (E11.x), obesity (E66.x), or other systemic conditions, code these as well

Documentation Requirements:

For optimal coding, the radiology report should specify:

  • Exact location within pancreas
  • Size measurements
  • Density characteristics (Hounsfield units on CT)
  • Enhancement pattern
  • Associated findings (ductal dilation, atrophy, calcifications)
  • Comparison to prior imaging if available

Until definitive characterization is achieved through additional imaging or tissue sampling, K86.9 remains the most appropriate code for an unspecified low-density pancreatic abnormality.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.